Neoplasm Metastasis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2011-08-22
EMA Application withdrawn: Ibandronic Acid Hexal (ibandronic acid) — Hexal AG
The EMA withdrew the application for Ibandronic Acid Hexal (ibandronic acid) from the market. Therapeutic areas listed include hypercalcemia…